- Home
- Companies
- north america
- respiratory tract infection
Show results for
Refine by
Respiratory Tract Infection Suppliers In North America
21 companies found
based inMontreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...
based inDavis, CALIFORNIA (USA)
Gold Standard Diagnostics provides comprehensive diagnostic solutions that improve lab efficiency and minimize overall costs. Through an extensive product menu, automated instrument platforms, and outstanding customer service, we solve real ...
The Adenovirus IgG-ELISA is intended for the qualitative determination of IgG class antibodies against Adenovirus in human serum or plasma (citrate, ...
based inCarlstadt, NEW JERSEY (USA)
Mada is a manufacturer and supplier of over 400 Medical, Dental, Pediatric and Veterinary products catering to the Home Healthcare and Institutional markets. Mada was incorporated in 1969, with Production and Corporate Offices located in Carlstadt, ...
based inCincinnati, OHIO (USA)
Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic and life science products. We are dedicated to developing and delivering better solutions that give ...
based inSalt Lake City, UTAH (USA)
BioFire Diagnostics sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. As BioMérieux’s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and ...
SARS-CoV-2 is a top concern for patients and clinicians, but several respiratory pathogens can cause nearly indistinguishable symptoms. The FDA De Novo authorized BioFire RP2.1 Panel is a frontline test to help clinicians quickly diagnose ...
based inBozeman, MONTANA (USA)
Microbion is a clinical-stage pharmaceutical company developing a novel class of compounds for the treatment of difficult-to-treat infections, including chronic infections and antibiotic-resistant infections. Microbion is dedicated to developing ...
Cystic Fibrosis (CF) lung disease, which is estimated to affect more than 30,000 in the US and 70,000 worldwide1, is characterized by chronic bacterial infection and severe inflammation that leads to progressive deterioration in lung function. ...
based inHouston, TEXAS (USA)
Azure Biotech Inc is a global biotechnology company that specializes in research & development, as well as the production and sales of diagnostic reagents, POCT analyzers and biological materials. Azure Biotech is also heavily involved in research ...
Strep A. Specimen Used: Swab/ nasal wash. Test Format: Device. CE mark: ...
based inBedford, MASSACHUSETTS (USA)
Genabio Diagnostics is transforming testing for companies and their employees by offering a low-cost, easy-to-use, point-of-care diagnostic platform for infectious diseases and drug abuse testing. Genabio’s testing system is designed to provide ...
based inAlbuquerque, NEW MEXICO (USA)
Nob Hill Therapeutics mission is to commercialize the first of its kind dry powder nebulizer (DryNeb) inhalation drug delivery platform. NHT is focused on creating effective inhalation therapies to address lower respiratory tract infections (the 5th ...
based inLansing, MICHIGAN (USA)
Neogen Corporation (NASDAQ: NEOG) now operates out of multiple U.S. and international locations, and has a worldwide presence. Neogen develops, manufactures and markets a diverse line of products dedicated to food and animal safety. Neogen ...
UNIPRIM is an FDA approved, fast-acting, powerful antibiotic for horses used to treat a wide spectrum of bacterial infections. A combination of 67 mg trimethoprim and 333 mg sulfadiazine per gram provides effective antibacterial activity. UNIPRIM ...
based inPearl River, NEW YORK (USA)
Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a ...
INBRIJA is a prescription medicine used when needed for OFF episodes in adults with Parkinson’s treated with regular carbidopa/levodopa medicine. INBRIJA does not replace regular carbidopa/levodopa ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired ...
based inAlameda, CALIFORNIA (USA)
Alveo is leading the transformation of the consumer health tech market by developing a low-cost, easy- to-use, at-home diagnostic platform that has the potential to change the way infectious diseases are detected & managed.The company’s be.well ...
based inSilver Spring, MARYLAND (USA)
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC). Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical ...
Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional ...
based inIrvine, CALIFORNIA (USA)
Established in 2011, Pathnostics is driven to pioneer a better future for physicians, patients, and the healthcare system with solutions that transform diagnostic and therapeutic dilemmas. Core capabilities in infectious disease and cancer ...
The Pathnostics Respiratory Pathogens Test is a highly specific and sensitive multiplex PCR for the nucleic acid detection of SARS-Cov-2, Influenza A, Influenza B, or respiratory syncytial virus (RSV). Using one nasal swab, our Respiratory Pathogens ...
based inNew York, NEW YORK (USA)
Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential ...
based inBurnaby, BRITISH COLUMBIA (CANADA)
Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination ...
The goal of personalized medicine is to achieve optimal therapy for each patient based on his or her genomic profile. In infectious or host-dependent diseases, this means therapies that also take into account the pathogen’s mutating ...
based inPearl River, NEW YORK (USA)
Auro Vaccines LLC is a clinical-stage vaccine development company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines for infectious diseases. Our novel approach is based on a proprietary ...
based inAnn Arbor, MICHIGAN (USA)
BlueWillow Biologics is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing intranasal vaccines using its patented nanoemulsion platform. The platform, originally discovered at the University of ...
BlueWillow’s vaccine technology incorporates nano-scale droplets that are manufactured at an average size of 400–500 nanometers to deliver and adjuvant a broad spectrum of ...
based inRockville, MARYLAND (USA)
Headquartered in Rockville, Maryland, OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop ...
The FDA-cleared Unyvero LRT panels enable unique and comprehensive detection of the most clinically relevant pathogens and antibiotic resistance markers that cover more than 90% of the most common causative agents of pneumonia, providing clinicians ...